Blue-chip Anglesea investment opportunity

COLLIERS  has recently listed an excellent freehold opportunity in Anglesea’s blue-chip retail precinct that boasts a famous Great Ocean Road address.

Home to one of Anglesea’s most respected businesses, 93 Great Ocean Road is leased to Anglesea Healthcare, the town’s only pharmacy and a vital provider of health services to the local community.

This tightly held freehold asset in the heart of Anglesea’s bustling retail precinct is now available for purchase through Colliers Geelong, offering a rare combination of secure income and future development potential.

The building comprises 179sqm and is currently leased on a 3+3 year term generating a net annual income of $45,891, with annual rental increases.

The site spans approximately 440sqm with dual street frontages to Great Ocean Road and Walker Street and is zoned Commercial 1 (C1Z) and General Residential (GRZ), presenting significant mixed-use development potential (STCA).

Colliers senior executive Ned Tansey said this is a standout opportunity to secure a freehold investment along one of Australia’s most iconic coastal routes.

“Assets like this are incredibly scarce along the Great Ocean Road, especially those with secure essential service tenants and future development upside,” Mr Tansey said.

Positioned just 1.2km from Anglesea Beach, the property benefits from high exposure to passing traffic and is surrounded by complementary retailers including IGA, Australia Post, Bendigo Bank, and BWS, ensuring consistent local and tourist visitation.

“Anglesea continues to attract strong investor interest due to its lifestyle appeal and commercial resilience,” Mr Tansey explained.

“With limited premium assets currently available across the Surf Coast and Greater Geelong, we’ve seen a marked increase in enquiries over the past six months.”

Just 36km from Geelong and 112km from Melbourne CBD, Anglesea is a thriving coastal town known for its pristine beaches, scenic trails, and vibrant community, making this an exceptional opportunity for investors seeking exposure to a high-performing regional market.

Expression of interest closes Thursday, November 27 at 2pm, unless sold prior.